379 related articles for article (PubMed ID: 31551675)
1. Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration.
González-Casacuberta I; Juárez-Flores DL; Morén C; Garrabou G
Front Neurosci; 2019; 13():894. PubMed ID: 31551675
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
5. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2
Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
[TBL] [Abstract][Full Text] [Related]
7. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Koentjoro B; Park JS; Sue CM
Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
[TBL] [Abstract][Full Text] [Related]
8. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.
Zhang J; Culp ML; Craver JG; Darley-Usmar V
J Neurochem; 2018 Mar; 144(6):691-709. PubMed ID: 29341130
[TBL] [Abstract][Full Text] [Related]
12. Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism.
Pacelli C; Rotundo G; Lecce L; Menga M; Bidollari E; Scrima R; Cela O; Piccoli C; Cocco T; Vescovi AL; Mazzoccoli G; Rosati J; Capitanio N
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195749
[TBL] [Abstract][Full Text] [Related]
13. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.
Van Laar VS; Roy N; Liu A; Rajprohat S; Arnold B; Dukes AA; Holbein CD; Berman SB
Neurobiol Dis; 2015 Feb; 74():180-93. PubMed ID: 25478815
[TBL] [Abstract][Full Text] [Related]
14. PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.
Mouton-Liger F; Jacoupy M; Corvol JC; Corti O
Front Mol Neurosci; 2017; 10():120. PubMed ID: 28507507
[TBL] [Abstract][Full Text] [Related]
15. Mitophagy and Parkinson's disease: be eaten to stay healthy.
de Vries RL; Przedborski S
Mol Cell Neurosci; 2013 Jul; 55():37-43. PubMed ID: 22926193
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.
Smith GA; Jansson J; Rocha EM; Osborn T; Hallett PJ; Isacson O
Mol Neurobiol; 2016 Oct; 53(8):5161-77. PubMed ID: 26399642
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunctions in Parkinson's disease.
Gautier CA; Corti O; Brice A
Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
[TBL] [Abstract][Full Text] [Related]
18. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.
Ambrosi G; Ghezzi C; Sepe S; Milanese C; Payan-Gomez C; Bombardieri CR; Armentero MT; Zangaglia R; Pacchetti C; Mastroberardino PG; Blandini F
Biochim Biophys Acta; 2014 Sep; 1842(9):1385-94. PubMed ID: 24854107
[TBL] [Abstract][Full Text] [Related]
19. Balance is the challenge--the impact of mitochondrial dynamics in Parkinson's disease.
Burbulla LF; Krebiehl G; Krüger R
Eur J Clin Invest; 2010 Nov; 40(11):1048-60. PubMed ID: 20735469
[TBL] [Abstract][Full Text] [Related]
20. Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Zeng XS; Geng WS; Jia JJ; Chen L; Zhang PP
Front Aging Neurosci; 2018; 10():109. PubMed ID: 29719505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
